8/21/2014

The U.S. Justice Department notified British drugmaker AstraZeneca on Tuesday that it has closed its investigation into an 18,000-patient clinical study of the blood thinner Brilinta. The DOJ plans no further action.

Full Story:
ABC News

Related Summaries